Raltegravir and Gallbladder attack - a phase IV clinical study of FDA data

Summary:

Gallbladder attack is reported as a side effect among people who take Raltegravir (raltegravir), especially for people who are male, 40-49 old, also take Daklinza, and have Hepatitis c.

The phase IV clinical study analyzes which people have Gallbladder attack when taking Raltegravir. It is created by eHealthMe based on reports of 5,050 people who have side effects when taking Raltegravir from the FDA, and is updated regularly.

What is Raltegravir?

Raltegravir has active ingredients of raltegravir. eHealthMe is studying from 5,054 Raltegravir users. Check the latest studies of Raltegravir.

What is Gallbladder attack?

Gallbladder attack (gallstones, gallbladder disease and gallbladder pain) is found to be associated with 536 drugs and 999 conditions by eHealthMe. Check the latest studies of Gallbladder attack.

On Apr, 24, 2026

5,050 people reported to have side effects when taking Raltegravir.
Among them, 11 people (0.22%) have Gallbladder attack.

Could Raltegravir cause Gallbladder attack?

Among these 11 people:

What is the gender of people who have Gallbladder attack when taking Raltegravir? *

female: 0.0 %
male: 100 %

What is the age of people who have Gallbladder attack when taking Raltegravir? *

What are other drugs people take besides Raltegravir? *

What are other side effects people have besides Gallbladder attack? *

Hyperbilirubinaemia (excess of bilirubin in the blood): 11 people, 100.00%
Kidney Stones: 10 people, 90.91%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 10 people, 90.91%
Haemoglobin Decreased: 10 people, 90.91%
Gallstones (stone formation by bile component): 10 people, 90.91%
Anaemia (lack of blood): 9 people, 81.82%
Renal Tubular Disorder (disease of kidney tubules): 8 people, 72.73%
Renal Disorder (kidney disease): 8 people, 72.73%
Haemolytic Anaemia (anaemia due to haemolysis): 5 people, 45.45%
Interstitial Nephritis (inflammation of the kidney): 4 people, 36.36%

What are the existing conditions these people have? *

Hiv Infection: 11 people, 100.00%
Hepatitis C: 11 people, 100.00%
Nausea (feeling of having an urge to vomit): 10 people, 90.91%
Indigestion: 10 people, 90.91%
Anaemia (lack of blood): 10 people, 90.91%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 7 people, 63.64%
Drug Dependence: 5 people, 45.45%
Chronic Hepatitis (long lasting inflammation of liver): 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take Raltegravir and have Gallbladder attack?

- Check whether Gallbladder attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Raltegravir:

Raltegravir (5,054 reports)

Browse all side effects of Raltegravir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gallbladder attack:

Gallbladder attack (536 drugs)

Browse all the conditions that are associated with Gallbladder attack:

Gallbladder attack (999 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raltegravir (the active ingredients of Raltegravir) and Raltegravir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.